Skip to main content
. 2021 Jul-Aug;37(4):1001–1007. doi: 10.12669/pjms.37.4.3471

Table-III.

Diagnostic & therapeutic delay (Lag-3 & Lag-4) with disease outcome.

Groups Lag time N% DAS28 Mean ±SD P-value HAQ-DI Mean ±SD P-value
Lag-3 Group 1 ≤1 year 60(58.8%) 4.04±1.37 0.02 0.55±0.44 0.01
Group 2 >1 year-<5 years 19(18.6%) 4.58±1.5 0.61±0.40
Group 3 >5 years 23(22.5%) 5.01±1.65 0.87±0.48
Lag-4 Group 1 ≤1 year 50(49%) 3.9±1.42 0.01 0.499±0.44 0.00
Group 2 >1 year-<5 years 19(18.6%) 4.5±1.32 0.66±0.38
Group 3 >5 years 33 (32.4) 4.9±1.57 0.82±0.46

Annova was used to compare mean DAS28 & HAQ-DI between groups (group1-group3) for both lag3 and lag4 (p value<0.05 significant).